These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 19014899

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Sodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsy.
    U.S. Xyrem Multicenter Study Group.
    Sleep Med; 2004 Mar; 5(2):119-23. PubMed ID: 15033130
    [Abstract] [Full Text] [Related]

  • 6. Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patients.
    Xyrem International Study Group.
    Sleep Med; 2005 Sep; 6(5):415-21. PubMed ID: 16099718
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy.
    Sleep; 2002 Feb 01; 25(1):42-9. PubMed ID: 11833860
    [Abstract] [Full Text] [Related]

  • 9. Narcolepsy: action of two gamma-aminobutyric acid type B agonists, baclofen and sodium oxybate.
    Huang YS, Guilleminault C.
    Pediatr Neurol; 2009 Jul 01; 41(1):9-16. PubMed ID: 19520267
    [Abstract] [Full Text] [Related]

  • 10. Long-term follow-up of patients with narcolepsy-cataplexy treated with sodium oxybate (Xyrem).
    Alshaikh MK, Gacuan D, George S, Sharif M, Bahammam AS.
    Clin Neuropharmacol; 2011 Jul 01; 34(1):1-4. PubMed ID: 21206362
    [Abstract] [Full Text] [Related]

  • 11. The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy.
    Black J, Pardi D, Hornfeldt CS, Inhaber N.
    Sleep Med; 2009 Sep 01; 10(8):829-35. PubMed ID: 19616998
    [Abstract] [Full Text] [Related]

  • 12. Sodium oxybate in narcolepsy with cataplexy: Zurich sleep center experience.
    Poryazova R, Tartarotti S, Khatami R, Baumann CR, Valko P, Kallweit U, Werth E, Bassetti CL.
    Eur Neurol; 2011 Sep 01; 65(3):175-82. PubMed ID: 21389728
    [Abstract] [Full Text] [Related]

  • 13. Sodium oxybate for narcolepsy.
    Scharf MB.
    Expert Rev Neurother; 2006 Aug 01; 6(8):1139-46. PubMed ID: 16893342
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Narcolepsy: treatment issues.
    Roth T.
    J Clin Psychiatry; 2007 Aug 01; 68 Suppl 13():16-9. PubMed ID: 18078361
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Off-label treatment of severe childhood narcolepsy-cataplexy with sodium oxybate.
    Murali H, Kotagal S.
    Sleep; 2006 Aug 01; 29(8):1025-9. PubMed ID: 16944670
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The pharmacokinetics of sodium oxybate oral solution following acute and chronic administration to narcoleptic patients.
    Borgen LA, Okerholm RA, Lai A, Scharf MB.
    J Clin Pharmacol; 2004 Mar 01; 44(3):253-7. PubMed ID: 14973300
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.